本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

334.13
-14.6000-4.19%
盘后334.130.00000.00%17:38 EDT
成交量:32.60万
成交额:1.10亿
市值:74.19亿
市盈率:-18.60
高:351.20
开:350.00
低:331.24
收:348.73
数据加载中...
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report